Clinical Trial Update: The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of raltitrexed for injection in combination with nab-paclitaxel for advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Raltitrexed for Injection (raltitrexed)

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer, Chemotherapy Effect | Phase 2 | Status: UNKNOWN